In 2024, an action group comprising VERBA LEGAL Law Firm, the National Medical Knowledge Base of the Association of Healthcare Artificial Intelligence Developers and Users and Digital Medicine Company, supported by Roche Moscow JSC, conducted an analytical survey to assess the approaches employed in Russia and abroad to granting access to and processing big data in healthcare, focusing on local regulatory barriers and international practices. A number of factors contributed to the relevance of the survey:

To start with, as part of the first phase of establishing the Unified State Health Information System and the Unified Digital Circuit most of the medical information has been digitized and the underlying infrastructure for healthcare digital transformation has been built. In this context, along with the transition to the "data economy", granting broad yet regulated access to anonymized medical data becomes increasingly important.

Secondly, the mechanisms that have been put into place to give access to big medical data allow carrying out in-depth analysis of the public demand and taking managerial and financial decisions on medicine provision to a whole new level, ensuring the “transparency” and efficiency of the procedures given the existing financial and organizational constraints.